Generation of synthetic aortic valve stenosis geometries for in silico trials
- PMID: 37961993
- DOI: 10.1002/cnm.3778
Generation of synthetic aortic valve stenosis geometries for in silico trials
Abstract
In silico trials are a promising way to increase the efficiency of the development, and the time to market of cardiovascular implantable devices. The development of transcatheter aortic valve implantation (TAVI) devices, could benefit from in silico trials to overcome frequently occurring complications such as paravalvular leakage and conduction problems. To be able to perform in silico TAVI trials virtual cohorts of TAVI patients are required. In a virtual cohort, individual patients are represented by computer models that usually require patient-specific aortic valve geometries. This study aimed to develop a virtual cohort generator that generates anatomically plausible, synthetic aortic valve stenosis geometries for in silico TAVI trials and allows for the selection of specific anatomical features that influence the occurrence of complications. To build the generator, a combination of non-parametrical statistical shape modeling and sampling from a copula distribution was used. The developed virtual cohort generator successfully generated synthetic aortic valve stenosis geometries that are comparable with a real cohort, and therefore, are considered as being anatomically plausible. Furthermore, we were able to select specific anatomical features with a sensitivity of around 90%. The virtual cohort generator has the potential to be used by TAVI manufacturers to test their devices. Future work will involve including calcifications to the synthetic geometries, and applying high-fidelity fluid-structure-interaction models to perform in silico trials.
Keywords: In silico trials; aortic valve stenosis; statistical shape modeling; synthetic geometries; transcatheter aortic valve implantation; virtual cohort.
© 2023 The Authors. International Journal for Numerical Methods in Biomedical Engineering published by John Wiley & Sons Ltd.
Similar articles
-
Emerging transcatheter heart valve technologies for severe aortic stenosis.Expert Rev Med Devices. 2023 Jul-Dec;20(12):1065-1077. doi: 10.1080/17434440.2023.2277229. Epub 2023 Nov 24. Expert Rev Med Devices. 2023. PMID: 37933200 Review.
-
Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.Catheter Cardiovasc Interv. 2020 Jan;95(1):E21-E29. doi: 10.1002/ccd.28339. Epub 2019 May 21. Catheter Cardiovasc Interv. 2020. PMID: 31115146
-
Comparison of hemodynamics in biological surgical aortic valve replacement and transcatheter aortic valve implantation: An in-silico study.Artif Organs. 2023 Feb;47(2):352-360. doi: 10.1111/aor.14405. Epub 2022 Sep 27. Artif Organs. 2023. PMID: 36114598
-
Performance of high conformability vs. high radial force devices in the virtual treatment of TAVI patients with bicuspid aortic valve.Med Eng Phys. 2021 Mar;89:42-50. doi: 10.1016/j.medengphy.2021.02.004. Epub 2021 Feb 5. Med Eng Phys. 2021. PMID: 33608124
-
The future of transcatheter aortic valve implantation.Eur Heart J. 2016 Mar 7;37(10):803-10. doi: 10.1093/eurheartj/ehv574. Epub 2015 Nov 17. Eur Heart J. 2016. PMID: 26578195 Review.
References
REFERENCES
-
- Henney A, Morley-Fletcher E, Contin M, Viceconti M. In silico clinical trials: How computer simulation will transform the biomedical industry. Int J Clin Trials. 2015;9:37-46.
-
- Morrison TM, Pathmanathan P, Adwan M, Margerrison E. Advancing regulatory science with computational modeling for medical devices at the fda's office of science and engineering laboratories. Front Med. 2018;5:241.
-
- Viceconti M, Cobelli C, Haddad T, Himes A, Kovatchev B, Palmer M. In silico assessment of biomedical products: the conundrum of rare but not so rare events in two case studies. Proc Inst Mech Eng. 2017;231(5):455-466.
-
- Ishizu K, Murakami N, Morinaga T, et al. Impact of tapered-shape left ventricular outflow tract on pacemaker rate after transcatheter aortic valve replacement. Heart Vessels. 2022;37:1-11.
-
- Condado JF, Corrigan FE III, Lerakis S, et al. Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2017;90(4):690-700.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources